Showing 1 – 20 of 796
Relevance | Newest | Oldest |
  • Achieving Diagnostic Excellence for Cancer: Symptom Detection as a Partner to Screening

    Abstract Full Text
    free access online first
    JAMA. 2022; doi: 10.1001/jama.2022.11744

    This Viewpoint discusses the need to expand early cancer detection to include both screening and symptom detection to achieve the goal of diagnostic excellence for cancer.

  • Changes in Cancer Screening Rates Following a New Cancer Diagnosis in a Primary Care Patient Panel

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(7):e2222131. doi: 10.1001/jamanetworkopen.2022.22131

    This cohort study examines whether primary care physicians’ exposures to patients with new diagnoses of breast or colorectal cancer were associated with changes in screening rates for other patients subsequently visiting the affected physicians.

  • Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis

    Abstract Full Text
    free access is active quiz has multimedia online first
    JAMA Oncol. 2022; doi: 10.1001/jamaoncol.2022.2617

    This systematic review and meta-analysis used databases, such as PubMed, ProQuest, and Scopus, to investigate the association between the COVID-19 pandemic and decreased rates of breast, colorectal, and cervical cancer screening globally.

  • Addressing Racial and Ethnic Differences in Diagnostic Resolution of Abnormal Mammographic Findings

    Abstract Full Text
    online first
    JAMA Oncol. 2022; doi: 10.1001/jamaoncol.2022.1864
  • Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(7):e2222092. doi: 10.1001/jamanetworkopen.2022.22092

    This cluster randomized clinical trial investigates the effects of patient and clinician decision support for BRCA1/2 genetic testing compared with standard education alone.

  • Stagnant US Mammography Rates and the Influence of COVID-19

    Abstract Full Text
    JAMA. 2022; 327(18):1742-1744. doi: 10.1001/jama.2022.4295

    This Medical News feature examines how the already stagnant mammography rates seen in recent years may be affected by the COVID-19 pandemic.

  • Facilitating Equitable, High-Quality Cancer Screening in the Post–COVID-19 Era

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(6):e2215496. doi: 10.1001/jamanetworkopen.2022.15496
  • Inclusion of the US Preventive Services Task Force Recommendation for Mammography in State Comprehensive Cancer Control Plans in the US

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(5):e229706. doi: 10.1001/jamanetworkopen.2022.9706

    This cross-sectional study evaluates the consistency of state comprehensive cancer control plan objectives compared with the 2016 US Preventive Services Task Force (USPSTF) recommendations for the age and frequency that women should undergo mammography.

  • Diagnostic Excellence and Patient Safety: Strategies and Opportunities

    Abstract Full Text
    JAMA. 2022; 327(24):2391-2392. doi: 10.1001/jama.2022.9629

    This Viewpoint examines diagnostic safety issues in various clinical scenarios across the care continuum, with selected examples illustrating successful strategies for improvement.

  • Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer Diagnosis

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(7):e2222214. doi: 10.1001/jamanetworkopen.2022.22214

    This cross-sectional study evaluates facility-level acceptance of Medicaid insurance among patients diagnosed with common cancers.

  • Bariatric Surgery and Cancer Risk

    Abstract Full Text
    JAMA. 2022; 327(24):2400-2402. doi: 10.1001/jama.2022.9166
  • Changes in Cancer Screening in the US During the COVID-19 Pandemic

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(6):e2215490. doi: 10.1001/jamanetworkopen.2022.15490

    This survey study examines changes in breast, cervical, and colorectal cancer screening prevalence during the COVID-19 pandemic in the US.

  • Why US Cervical Cancer Survival Rates Haven’t Improved for Decades

    Abstract Full Text
    JAMA. 2022; 327(20):1943-1945. doi: 10.1001/jama.2022.4681

    This Medical News feature examines why the US cervical cancer mortality rate remains stagnant despite the disease being highly preventable.

  • Cancer Incidence Among Adults With HIV in a Population-Based Cohort in Korea

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(8):e2224897. doi: 10.1001/jamanetworkopen.2022.24897

    This cohort study assesses the incidence and risk of cancer among people infected with HIV compared with the general population in Korea.

  • Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China

    Abstract Full Text
    open access
    JAMA Netw Open. 2022; 5(5):e2213634. doi: 10.1001/jamanetworkopen.2022.13634

    This economic evaluation compares the cost-effectiveness of lung cancer screening strategies using low-dose computed tomography (LDCT) and a plasma-based biomarker or LDCT alone in a simulated population of Chinese adults with a history of smoking.

  • Breast Cancer Screening Strategies for Women With ATM, CHEK2 , and PALB2 Pathogenic Variants: A Comparative Modeling Analysis

    Abstract Full Text
    JAMA Oncol. 2022; 8(4):587-596. doi: 10.1001/jamaoncol.2021.6204

    This decision analytical study uses microsimulation models from the Cancer Intervention and Surveillance Modeling Network to estimate the benefits and harms associated with breast cancer screening strategies using mammography and magnetic resonance imaging at various start ages for women with ATM, CHEK2, and PALB2 pathogenic variants.

  • Comparison of US Cancer Center Recommendations for Prostate Cancer Screening With Evidence-Based Guidelines

    Abstract Full Text
    JAMA Intern Med. 2022; 182(5):555-556. doi: 10.1001/jamainternmed.2022.0091

    This cross-sectional study examines prostate cancer recommendations among US cancer centers to identify differences from clinical practice guidelines.

  • Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic

    Abstract Full Text
    open access is active quiz
    JAMA Netw Open. 2022; 5(4):e228855. doi: 10.1001/jamanetworkopen.2022.8855

    This cohort study assesses changes in the volume of cancer care episodes during the first year of the COVID-19 pandemic in Ontario, Canada.

  • Trends in Cancer Mortality Among Black Individuals in the US From 1999 to 2019

    Abstract Full Text
    open access online first
    JAMA Oncol. 2022; doi: 10.1001/jamaoncol.2022.1472

    This cross-sectional study examines trends in cancer mortality among Black individuals in the US from 1999 to 2019 and compares mortality rates in 2019 between the Black population and other racial and ethnic populations.

  • Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial

    Abstract Full Text
    JAMA. 2022; 327(24):2413-2422. doi: 10.1001/jama.2022.9265

    This randomized clinical trial assesses the effect of using weekly electronic patient-reported outcome surveys to monitor symptoms, compared with usual care, on physical function, symptom control, and health-related quality of life among patients receiving treatment for metastatic cancer.